Novus Biologicals™ APRIL/TNFSF13 Antibody Blocking Peptide

Catalog No.	Quantity
NBP176767E	0.05 mg

Catalog No. NBP176767E Supplier Novus Biologicals™ Supplier No. NBP176767PEP

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide containing 15 amino acids near the extracellular domain of human APRIL. Source: Synthetic (Accession #: NP_003799) The APRIL/TNFSF13 Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

• Gene ID (Entrez): 8741
• Species: Human
• Content And Storage: Store at -20 C. Avoid freeze-thaw cycles.
• Formulation: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• For Use With (Application): This Peptide is Useful as a Blocking Peptide for NBP1-76767. For Further Blocking Peptide Related Protocol, Click Here .
• Gene Alias: A proliferation-inducing ligand, APRILFLJ57090, CD256, CD256 antigen, TALL2, TALL-2, TNF- and APOL-related leukocyte expressed ligand 2, TNF-related death ligand 1, TRDL-1, tumor necrosis factor (ligand) superfamily, member 13, tumor necrosis factor ligand superfamily member 13, tumor necrosis factor-like protein ZTNF2, tumor necrosis factor-related death ligand-1, ZTNF2
• Gene Symbol: TNFSF13
• Product Type: APRIL/TNFSF13
• Quantity: 0.05 mg
• Regulatory Status: RUO - research use only
• Source: Synthetic
• Termination: 15 amino acids near the extracellular domain of human APRIL